Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
CPI awarded globally recognised certificate for food safety
The certification is a vital step towards CPI helping startup companies produce product samples which can then be tested for their texture and taste.
Jul 11 2023
CPI Enterprises to help fund innovative medical device for brain tumours
CPI Enterprises invests in QV Bioelectronics’ medical device that interrupts cancer cell division increasing long-term survival for brain tumour patients.
Jun 26 2023
CPI to develop digital bioprocess modelling techniques to help bring innovative treatments to market faster
CPI awarded £1.9 million to develop first-of-its-kind digital approach to bioprocess modelling to help bring innovative treatments to market faster.
Jun 12 2023
CPI and VaxEquity collaboration aims to advance the manufacturing of innovative vaccines and treatments
A grant of almost £700,000 has been awarded by Innovate UK to VaxEquity and CPI to develop the manufacturing process of innovative vaccines and treatments.
Jun 05 2023
Novel drug delivery one-stop shop
We’re establishing a brand-new Intracellular Drug Delivery Centre, alongside our partners, to develop novel RNA-based vaccines and therapeutics.
May 31 2023
NiTech-led project wins funds to develop new and innovative battery technology
NiTech Solutions’ CatContiCryst wins funding from UKRI’s Faraday Battery Challenge to develop a new technology for Li-ion batteries for electric vehicles.
May 18 2023
Wearable technology for stroke survivors could help up to 50% of patients
A first-of-its-kind wearable device for stroke survivors could help up to 50% of stroke survivors recover movement in their arms and hands.
May 17 2023
Scaling up e‑waste recycling with Descycle investment
CPI Enterprises invests in disruptive deep tech company, Descycle, who offer a clean and efficient metal processing alternative to traditional smelting.
Mar 17 2023
New consortium aims to expand patient access to life-saving oligonucleotide therapeutics
CPI is set to boost oligonucleotide manufacture through a £2.7 million 3‑year partnership with AstraZeneca, Novartis, and The University of Manchester.
